Holen Sie sich die Stockscreener-App
5.50
4.01%
-0.23
Handel nachbörslich:
5.64
0.14
+2.55%
Schlusskurs vom Vortag:
$5.73
Offen:
$5.76
24-Stunden-Volumen:
20,698
Relative Volume:
1.45
Marktkapitalisierung:
$48.38M
Einnahmen:
$1.75B
Nettoeinkommen (Verlust:
$-9.95M
KGV:
-5.1848
EPS:
-1.0608
Netto-Cashflow:
$16.55M
1W Leistung:
-8.33%
1M Leistung:
-19.94%
6M Leistung:
+50.27%
1J Leistung:
-29.49%
1-Tages-Spanne:
$5.50
$5.80
1-Wochen-Bereich:
$5.50
$6.365
52-Wochen-Spanne:
$2.48
$11.17
111 Inc Adr Stock (YI) Company Profile
Firmenname
111 Inc Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare YI vs MCK, COR, CAH, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
YI
111 Inc Adr
|
5.50 | 50.41M | 1.75B | -9.95M | 16.55M | -1.0608 |
MCK
Mckesson Corp
|
766.26 | 90.72B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
265.45 | 51.51B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
200.68 | 46.66B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
73.51 | 8.34B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
1.51 | 1.37B | 14.85M | -136.07M | 7.25M | -0.4726 |
111 Inc Adr Stock (YI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-15 | Fortgesetzt | Citigroup | Buy |
111 Inc Adr Aktie (YI) Neueste Nachrichten
111 Inc stock (KYG6769N1008): Chinese online pharmacy share under pressure amid shifting healthcare - AD HOC NEWS
Korro Bio Selects KRRO-111 as RNA Editing Therapy Candidate for Alpha-1 Antitrypsin Deficiency (AATD) with Best-in-Class Preclinical Results 1 - Minichart
Korro Bio, Inc. selects KRRO-111 after preclinical success in repairing AAT protein - Traders Union
Asian Equities Traded in the US as American Depositary Receipts Lower in Monday Trading - Moomoo
BASF SE stock (DE000BASF111): dividend profile and business outlook after latest payout - AD HOC NEWS
T. Rowe Price (OS) files 13G/A reporting 111 shares; 0.0% ownership - Stock Titan
KBS Real Estate Investment Trust III (KBSR) warns on going concern amid $1.2B near-term debt load - Stock Titan
111 Inc stock (KYG6769N1008): Analyst upgrade to Hold amid recent price volatility - AD HOC NEWS
RSU awards lift 111, Inc. (YI) director Teo Nee Chuan’s holdings to 811,889 - Stock Titan
Director Chen Yang Luke granted 413,168 RSUs at 111, Inc. (YI) as equity awards - Stock Titan
Large RSU grants to 111, Inc. (YI) director boost reported holdings - Stock Titan
111, Inc. (YI) director granted over 790,000 RSUs in new awards - Stock Titan
Redemption pressure, China rules shape 111, Inc. (NASDAQ: YI) outlook - Stock Titan
Read the full transcript of King Charles III’s speech to U.S. Congress - Global News
How to watch King Charles III’s historic address to Congress live - Fast Company
King Charles US visit: What to know about the itinerary, Congress address - Al Jazeera
AIR merger gives CAEP (NASDAQ: CAEP) holders new Pubco AIIR shares - Stock Titan
King Charles to Honor Queen Elizabeth in Recorded Address in Honor of Her 100th Birthday - People.com
Jian David Sun Net Worth (2026) - GuruFocus
Yang Luke Chen Net Worth (2026) - GuruFocus
Yu Gang Net Worth (2026) - GuruFocus
Nee Chuan Teo Net Worth (2026) - GuruFocus
Jun Justin Luo Net Worth (2026) - GuruFocus
111 (NASDAQ:YI) Shares Up 3.2%Should You Buy? - MarketBeat
111, Inc. Posts 2025 Profitability Milestone as Asset-Light Pivot Lifts Margins - The Globe and Mail
111, Inc. (NASDAQ: YI) trims 2025 revenue while edging toward operating profit - Stock Titan
111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results - The Manila Times
Winter Organization snags pair of leases in Flatiron offices - The Real Deal
111 Inc. (YI) Eps Diluted (TTM) - Zacks Investment Research
Precision Trading with 111 Inc. (YI) Risk Zones - Stock Traders Daily
Hub Group (HUBG) CAO reports 111-share tax withholding and 81-share correction - Stock Titan
YI Stock Analysis: 111 Inc. American Depositary Shares 3.3% Dip to $6.44 Recap - Newser
Insulet (PODD) board member elects 111 deferred stock units as fees - Stock Titan
Ultragenyx (RARE) gets FDA review date for UX111 gene therapy on Sept. 19, 2026 - Stock Titan
King Charles III to address Congress on April 28 - CBS News
Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation - Novartis
Walmart makes rare, harsh choice amid 'power buyer' controversy - thestreet.com
America’s Biggest Retailer Walmart to Cut 111 Jobs at Matteson Site - WhatNow
symbol__ Stock Quote Price and Forecast - CNN
111 Inc Stock: Pioneering China's Online Healthcare Retail with Global Investor Potential - AD HOC NEWS
111 Inc Stock: Micro-Cap Healthcare Leader in China's Digital Pharmacy Space Faces Profit Challenges - AD HOC NEWS
Agilent Technologies Inc. stock rises on advanced chromatography solutions launch boosting lab effic - AD HOC NEWS
111 (NASDAQ:YI) Shares Down 2.2%What's Next? - MarketBeat
111, Inc. (YI) director reports 19,984 fully vested RSUs on Form 3 - stocktitan.net
Director Luo Jun Justin reports 18,366 vested RSUs in 111, Inc. (YI) - Stock Titan
111, Inc. (YI) director Sun Jian David reports 18,366 vested RSUs - stocktitan.net
111, Inc. (YI) director Chen Yang Luke reports 126,295 fully vested RSUs - Stock Titan
Liu Junling discloses major equity stake in 111, Inc. (YI) on Form 3 - Stock Titan
Gang Yu details large equity stake in 111, Inc. (YI) Form 3 filing - Stock Titan
111 Inc Stock (ISIN: KYG6769N1008) Faces Headwinds Amid China E-Commerce Slowdown - AD HOC NEWS
Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 - GlobeNewswire
Finanzdaten der 111 Inc Adr-Aktie (YI)
Umsatz
Nettogewinn
Free Cashflow
ENV
8.83%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):